We are live on
!
Find out more
GP
Grow Partners Portfolio holdings
AUM
$4.81M
1-Year Est. Return
7.86%
This Fund
S&P 500
This Quarter
Est. Return
-1.78%
1 Year Est. Return
+7.86%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.81M
AUM Growth
-$104M
(-96%)
Cap. Flow
-$102M
Cap. Flow
% of AUM
-2,111.78%
Top 10 Holdings %
Top 10 Hldgs %
98.13%
Holding
34
New
5
Increased
–
Reduced
8
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Veeva Systems
VEEV
|
+$564K |
| 2 |
PBPB
Potbelly
PBPB
|
+$458K |
| 3 |
BDSI
BioDelivery Sciences International, Inc.
BDSI
|
+$410K |
| 4 |
MATR
Mattersight Corp.
MATR
|
+$159K |
| 5 |
Cumberland Pharmaceuticals
CPIX
|
+$62.4K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SAAS
inContact, Inc.
SAAS
|
+$9.59M |
| 2 |
Ligand Pharmaceuticals
LGND
|
+$7.32M |
| 3 |
INFN
Infinera Corporation Common Stock
INFN
|
+$7.18M |
| 4 |
Covenant Logistics
CVLG
|
+$7.13M |
| 5 |
ZLTQ
ZELTIQ Aesthetics, Inc.
ZLTQ
|
+$6.98M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 37.31% |
| 2 | Technology | 26.89% |
| 3 | Industrials | 12.67% |
| 4 | Consumer Discretionary | 9.4% |
| 5 | Financials | 0.21% |
Similar funds
GH
STIA
RCM
BPCM
KC
AIM
NA
LSVI
Grow Partners's Q1 2015 Portfolio in Review
As of Q1 2015, Grow Partners held 34 positions worth $4.81M, down 96% from $109M the previous quarter. Its ten largest holdings account for 98% of the portfolio.
Grow Partners withdrew a net $102M in Q1 2015, closing 21 positions and reducing 8 holdings. Its most notable exit was Ligand Pharmaceuticals, an estimated $7.32M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 34% a quarter earlier, followed by Technology and Industrials.
Against the trend, Grow Partners opened a new position in Veeva Systems worth $511K.
- Grow Partners's largest Q1 2015 buy was Veeva Systems: 20,000 shares worth $511K.
- Grow Partners's biggest Q1 2015 reduction was inContact, Inc., cutting an estimated $9.59M.
- Grow Partners fully exited Ligand Pharmaceuticals in Q1 2015, selling an estimated $7.32M.
- Grow Partners's ten largest holdings make up 98% of its $4.81M portfolio in Q1 2015.
- Grow Partners opened 5 new positions and closed 21 in Q1 2015.
- Grow Partners's portfolio value fell 96% quarter-over-quarter to $4.81M.
Based on Grow Partners's 13F filing for Q1 2015, filed 18 May 2015.